442 related articles for article (PubMed ID: 15814644)
1. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
3. Estrogens decrease gamma-ray-induced senescence and maintain cell cycle progression in breast cancer cells independently of p53.
Toillon RA; Magné N; Laïos I; Castadot P; Kinnaert E; Van Houtte P; Desmedt C; Leclercq G; Lacroix M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1187-200. PubMed ID: 17336220
[TBL] [Abstract][Full Text] [Related]
4. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
Wosikowski K; Regis JT; Robey RW; Alvarez M; Buters JT; Gudas JM; Bates SE
Cell Growth Differ; 1995 Nov; 6(11):1395-403. PubMed ID: 8562478
[TBL] [Abstract][Full Text] [Related]
5. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
Vigneron A; Roninson IB; Gamelin E; Coqueret O
Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
[TBL] [Abstract][Full Text] [Related]
6. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.
Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB
Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bax, Bad and Bcl-2 proteins under x-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives.
Chorna IV; Datsyuk LO; Stoika RS
Exp Oncol; 2005 Sep; 27(3):196-201. PubMed ID: 16244580
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity, expression of Bcl-2 and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines.
Yoon KA; Ku JL; Yang JO; Park JG
Int J Mol Med; 2003 Mar; 11(3):343-8. PubMed ID: 12579337
[TBL] [Abstract][Full Text] [Related]
9. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
[TBL] [Abstract][Full Text] [Related]
11. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Ravizza R; Gariboldi MB; Molteni R; Monti E
Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
[TBL] [Abstract][Full Text] [Related]
12. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
14. Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage.
Maejima Y; Adachi S; Ito H; Hirao K; Isobe M
Aging Cell; 2008 Mar; 7(2):125-36. PubMed ID: 18031568
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
16. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
[TBL] [Abstract][Full Text] [Related]
17. E2F-1 is a critical modulator of cellular senescence in human cancer.
Park C; Lee I; Kang WK
Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-beta production.
Chorna I; Bilyy R; Datsyuk L; Stoika R
Exp Oncol; 2004 Jun; 26(2):111-7. PubMed ID: 15273662
[TBL] [Abstract][Full Text] [Related]
19. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
20. Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.
Li X; Lu Y; Liang K; Liu B; Fan Z
Breast Cancer Res; 2005; 7(5):R589-97. PubMed ID: 16168102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]